Fatty aldehyde dehydrogenase: Genomic structure, expression and mutation analysis in Sjögren-Larsson syndrome

Chemico-Biological Interactions

Volumn 130-132, Issue , 2001, Pages 297-307

  Rizzo, William B ^a   Lin, Zhili ^a   Carney, Gael ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aldehyde dehydrogenase; Fatty aldehyde; Mutation; Sj gren Larsson syndrome

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 3A2; FATTY ALCOHOL; GLYCEROLIPID; LEUKOTRIENE B4; MICROSOME ENZYME; PHYTANIC ACID; PROTEIN; UNCLASSIFIED DRUG;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; CATALYSIS; CONFERENCE PAPER; GENE EXPRESSION; GENE MUTATION; GENE STRUCTURE; GENETIC LINKAGE; GENOME; HUMAN; ICHTHYOSIS; MENTAL DEFICIENCY; MOUSE; NONHUMAN; OXIDATION; PROTEIN FOLDING; PROTEIN STABILITY; SJOEGREN LARSSON SYNDROME; SPASTICITY; STRUCTURE ACTIVITY RELATION;

ALDEHYDE OXIDOREDUCTASES; AMINO ACID SEQUENCE; ANIMALS; GENE EXPRESSION; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; MUTATION, MISSENSE; POLYMORPHISM, GENETIC; SEQUENCE HOMOLOGY, AMINO ACID; SJOGREN-LARSSON SYNDROME; SPECIES SPECIFICITY;

EID: 0035969896     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(00)00273-8     Document Type: Conference Paper

References (49)

1. A new pteridine-requiring enzyme system for the oxidation of glyceryl ethers
2. Tissue and subcellular distribution of mammalian aldehyde-oxidizing capacity
3. The subcellular distribution and properties of aldehyde dehydrogenses in rat liver
4. Different forms of rat liver aldehyde dehydrogenase and their subcellular distribution
5. Subcellular distribution and characterization of human liver aldehyde dehydrogenase fractions
6. Purification and properties of a membrane-bound aldehyde dehydrogenase from rat liver microsomes
7. Purification of aldehyde dehydrogenase reconstitutively active in fatty alcohol oxidation from rabbit intestinal microsomes
8. Human liver fatty aldehyde dehydrogenase: Microsomal localization, purification, and biochemical characterization
9. Sjögren-Larsson syndrome: Impaired fatty alcohol oxidation in cultured fibroblasts due to deficient fatty alcohol:nicotinamide adenine dinucleotide oxidoreductase activity
10. Rat liver aldehyde dehydrogenase. I. Isolation and characterization of four high Km normal liver isozymes
11. Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase
12. Mutations associated with Sjögren-Larsson syndrome
13. Biogenesis of microsomal aldehyde dehydrogenase in rat liver
14. Microsomal aldehyde dehydrogenase or its cross-reacting protein exists in outer mitochondrial membranes and peroxisomal membranes in rat liver
15. Defective inactivation of leukotriene B4 in patients with Sjögren-Larsson syndrome
16. Molecular cloning, sequencing, and expression of cDNA for rat liver microsomal aldehyde dehydrogenase
17. Mouse microsomal class 3 aldehyde dehydrogenase: AHD3 cDNA sequence, inducibility by dioxin and clofibrate, and genetic mapping
18. Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene
19. Microsomal aldehyde dehydrogenase is localized to the endoplasmic reticulum via its carboxyl-terminal 35 amino acids
20. Relationships within the aldehyde dehydrogenase extended family
21. The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold
22. Eukaryotic aldehyde dehydrogenase (ALDH) genes: Human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping
23. Genomic organization and expression of the human fatty aldehyde dehydrogenase gene (FALDH)
24. Human fatty aldehyde dehydrogenase gene (ALDH10): Organization and tissue-dependent expression
25. Genomic organization, expression and alternate splicing of the mouse fatty aldehyde dehydrogenase gene
26. Components involved in peroxisome import, biogenesis, proliferation, turnover, and movement
27. mRNA stability in mammalian cells
28. Transcription from TATA-less promoters: Dihydrofolate reductase as a model
29. Sjögren-Larsson syndrome: Fatty aldehyde dehydrogenase deficiency
30. Oligophrenia in combination with congenital ichthyosis and spastic disorders
31. Sjögren-Larsson syndrome is caused by a common mutation in northern European and Swedish patients
32. A common deletion mutation in European patients with Sjögren-Larsson syndrome
33. A missense mutation in the FALDH gene identified in Sjögren-Larsson syndrome patients originating from the northern part of Sweden
34. Spectrum of mutations and sequence variants in the FALDH gene in patients with Sjögren-Larsson syndrome
35. A novel 4 bp deletion mutation in the FALDH gene segregating in a Turkish family with Sjögren-Larsson syndrome
36. The molecular basis of Sjögren-Larsson syndrome: Mutation analysis of the fatty aldehyde dehydrogenase gene
37. Molecular basis of Sjögren-Larsson syndrome: Frequency of the 1297-1298 del GA and 943C > T mutation in 29 patients
38. A novel point mutation of the FALDH gene in a Japanese family with Sjögren-Larsson syndrome
39. RNA-based mutation screening in German families with Sjögren-Larsson syndrome
40. Mutagenic deamination of cytosine residues in DNA
41. DNA methylation and cancer
42. Sjögren-Larsson syndrome. Deficient activity of the fatty aldehyde dehydrogenase component of fatty alcohol:NAD oxidoreductase in cultured fibroblasts
43. Sjögren-Larsson syndrome: Inherited defect in the fatty alcohol cycle
44. Sjögren-Larsson syndrome
45. Sjögren-Larsson syndrome: Accumulation of free fatty alcohols in cultured fibroblasts and plasma
46. Characterization of fatty alcohol: NAD oxidoreductase from rat liver
47. Some properties of the fatty alcohol oxidation system and reconstitution of microsomal oxidation activity in intestinal mucosa
48. Microsomal fatty aldehyde dehydrogenase catalyzes the oxidation of aliphatic aldehyde derived from ether glycerolipid catabolism: Implications for Sjögren-Larsson syndrome
49. Involvement of microsomal fatty aldehyde dehydrogenase in the α-oxidation of phytanic acid